Last update 04 Mar 2025

Multivalent HIV-1 peptide immunogen vaccine(National Institute of Allergy & Infectious Diseases)

Overview

Basic Info

Drug Type
Synthetic peptide vaccine, Prophylactic vaccine
Synonyms-
Target
env
Mechanism
env inhibitors(Recombinant envelope protein inhibitors)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
HIV Infections
Originator Organization
National Institute of Allergy & Infectious Diseases
Active Organization-
Inactive Organization
National Institute of Allergy & Infectious DiseasesUnited Biomedical, Inc.United Biomedical, Inc.
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Multivalent HIV-1 peptide immunogen vaccine(National Institute of Allergy & Infectious Diseases)
NCT00000795
/ CompletedPhase 1IIT
A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects
100 Clinical Results associated with Multivalent HIV-1 peptide immunogen vaccine(National Institute of Allergy & Infectious Diseases)
Login to view more data
100 Translational Medicine associated with Multivalent HIV-1 peptide immunogen vaccine(National Institute of Allergy & Infectious Diseases)
Login to view more data
100 Patents (Medical) associated with Multivalent HIV-1 peptide immunogen vaccine(National Institute of Allergy & Infectious Diseases)
Login to view more data
100 Deals associated with Multivalent HIV-1 peptide immunogen vaccine(National Institute of Allergy & Infectious Diseases)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 1
US
National Institute of Allergy & Infectious Diseases
31 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free